Cancer Risk in Transgender People

被引：26
作者：
de Blok, Christel J. M. [1 ,2 ]
Dreijerink, Koen M. A. [1 ,2 ]
den Heijer, Martin [1 ,2 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam UMC, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam UMC, Ctr Expertise Gender Dysphoria, POB 7057, NL-1007 MB Amsterdam, Netherlands
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2019年 / 48卷 / 02期
关键词：
Transgender; Cancer; Sex hormones; Sex differences; FEMALE TRANSSEXUAL PERSONS; PROSTATE-CANCER; LONG-TERM; BREAST-CANCER; SEX-DIFFERENCES; OVARIAN-CANCER; PROGESTERONE-RECEPTORS; CERVICAL-CANCER; ESTROGEN; MORTALITY;
D O I：
10.1016/j.ecl.2019.02.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Gender-affirming hormonal treatment (HT) in transgender people is considered safe in general, but the question regarding (long-term) risk on sex hormone-related cancer remains. Because the risk on certain types of cancer differs between men and women, and some of these differences are attributed to exposure to sex hormones, the cancer risk may be altered in transgender people receiving HT. Although reliable epidemiologic data are sparse, the available data will be discussed in this article. Furthermore, recommendations for cancer screening and prevention will be discussed as well as whether to withdraw HT at time of a cancer diagnosis.
引用
收藏
页码：441 / +
页数：14
相关论文
共 69 条
  • [1] Afshar N, 2018, CANCER CAUSE CONTROL, V29, P1059, DOI 10.1007/s10552-018-1079-z
  • [2] [Anonymous], LGBT HLTH
  • [3] [Anonymous], END ABSTR
  • [4] Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases
    Arnold, Arthur P.
    Cassis, Lisa A.
    Eghbali, Mansoureh
    Reue, Karen
    Sandberg, Kathryn
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (05) : 746 - 756
  • [5] MORTALITY AND MORBIDITY IN TRANSSEXUAL PATIENTS WITH CROSS-GENDER HORMONE-TREATMENT
    ASSCHEMAN, H
    GOOREN, LJG
    EKLUND, PLE
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (09): : 869 - 873
  • [6] A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones
    Asscheman, Henk
    Giltay, Erik J.
    Megens, Jos A. J.
    de Ronde, W.
    van Trotsenburg, Michael A. A.
    Gooren, Louis J. G.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (04) : 635 - 642
  • [7] Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and -β expression of young women
    Baldassarre, M.
    Giannone, F. A.
    Foschini, M. P.
    Battaglia, C.
    Busacchi, P.
    Venturoli, S.
    Meriggiola, M. C.
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2013, 25 (05) : 172 - 177
  • [8] Androgen receptor expression in the human vagina under different physiological and treatment conditions
    Baldassarre, M.
    Perrone, A. M.
    Giannone, F. A.
    Armillotta, F.
    Battaglia, C.
    Costantino, A.
    Venturoli, S.
    Meriggiola, M. C.
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2013, 25 (01) : 7 - 11
  • [9] Occurrence, regulation, and significance of progesterone receptors in human meningioma
    Blankenstein, MA
    Verheijen, FM
    Jacobs, JM
    Donker, TH
    van Duijnhoven, MWF
    Thijssen, JHH
    [J]. STEROIDS, 2000, 65 (10-11) : 795 - 800
  • [10] Mortality Among Veterans with Transgender-Related Diagnoses in the Veterans Health Administration, FY2000-2009
    Blosnich, John R.
    Brown, George R.
    Wojcio, Sybil
    Jones, Kenneth T.
    Bossarte, Robert M.
    [J]. LGBT HEALTH, 2014, 1 (04) : 269 - 276
1234567